Hemolytic uremic syndrome induced by infusion of oxaliplatin: A case report

Tumori

Volumn 97, Issue 5, 2011, Pages

  Racca, Patrizia ^a   Spadi, Rosella ^a   Fora, Gianluca ^a   Fanchini, Laura ^a   Ritorto, Giuliana ^b   Ferrari, Laura ^a   Pinta, Francesco ^a   Lista, Patrizia ^b   Ciuffreda, Libero ^b  

^a MOLINETTE HOSPITAL   (Italy)

^b AOU San Giovanni Battista Molinette   (Italy)

Author keywords

Chemotherapy; Colorectal cancer; Hemolytic uremic syndrome; Oxaliplatin

Indexed keywords

BEVACIZUMAB; CORTICOSTEROID; CREATININE; FLUOROURACIL; FOLINIC ACID; FRESH FROZEN PLASMA; IRINOTECAN; LOOP DIURETIC AGENT; OXALIPLATIN; UREA;

ACUTE KIDNEY FAILURE; ADULT; ANAMNESIS; ANEMIA; ARTICLE; BACKACHE; BILIRUBIN BLOOD LEVEL; CANCER GROWTH; CANCER SURGERY; CASE REPORT; COLORECTAL CANCER; CONTINUOUS INFUSION; COOMBS TEST; CREATININE CLEARANCE; DRUG WITHDRAWAL; ENUCLEORESECTION; FEMALE; HEMATURIA; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FAILURE; LIVER METASTASIS; LIVER RESECTION; MULTIPLE CYCLE TREATMENT; OMENTUM DISEASE; PERITONEAL DISEASE; PERITONEUM METASTASIS; PLASMA TRANSFUSION; RADIOFREQUENCY ABLATION; REHYDRATION; SIDE EFFECT; SURGICAL TECHNIQUE; THROMBOCYTOPENIA; UPPER GASTROINTESTINAL BLEEDING; UREA BLOOD LEVEL;

EID: 83055193638     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161109700527     Document Type: Article

References (24)

1. Meyerhardt J, Mayer R: Systemic therapy for colorectal cancer. Engl J Med, 352: 476-487, 2005.
2. Cassidy J, Misset JL: Oxaliplatin-related side effects: characteristics and management. Semin Oncol, 29 (5 Suppl 15) 11-20, Oct 2002. (Pubitemid 35191037)
3. Hollenbeck M, Kutkuhn B: Haemolytic-uraemic syndrome and thrombotic-thrombocytopenic purpura in adults: clinical findings and prognostic factors for death and end-stage renal disease. Nephrol Dial Transplant, 13: 76-81, 1998. (Pubitemid 28033583)
4. Sens YA, Miorin LA, Silva HG, Malheiros DM, Filho DM, Jabur P: Acute renal failure due to hemolytic uremic syndrome in adult patients. Renal Fail, 19: 279-282, 1997. (Pubitemid 27147237)
5. Bancroft Lesesne J, Rothschild N: Cancer-associated hemolytic- uremic syndrome: analysis of 85 cases from a national registry. JCO, 7: 781-789, 1989.
6. Medina PJ: Drug-associated thromboic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opinion Hematol, 8: 286-293, 2001.
7. Saif MW, McGee PJ: Hemolytic-uremic syndrome associated with gemcitabine: A case report and review of literature. JOP, 6: 369-374, 2005. (Pubitemid 41581760)
8. Cobo F, De Celis G: Emolytic anemia: a oxaliplatin-induced immune anemia a case report and review of the literature. Anticancer Drugs, 18: 973-976, 2007. (Pubitemid 47220718)
9. Dahabreh I, Tsoutsos G, Tseligas D, Janinis D: Haemolytic uremic syndrome following the infusion of oxaliplatin: case report. BMC Clin Pharmacol, 6: 5, 2006.
10. Earle CC, Chen WY, Ryan DP, Mayer RJ: Oxaliplatin: induced Evan's syndrome. Br J Cancer, 84: 441, 2001.
11. Sorbye H, Bruserud O, Dahl O: Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis. Acta Oncol, 49: 882- 883, 2001.
12. Desrame J, Brustet H, Darodes de Tailly PD, Girard D, Saissy JM: Oxaliplatin-induced haemolytic anemia. Lancet, 354: 1179-1180, 1999.
13. Garufi C, Vaglio S, Brienza S, Conti L, D'Attino RM, Girelli G: Immunohemolytic anemia following oxaliplatin administration. Ann Oncol, 11: 497, 2000. (Pubitemid 30333559)
14. Dold FG, Mitchell EP: Sudden-onset thromobocytopenia with oxaliplatin. Ann Intern Med, 139: 156-157, 2003.
15. Chen VM, Thrift KM, Morel-Kopp MC, Jackson D, Ward CM, Flower RL: An immediate hemolytic reaction induced by repeated administration of oxaliplatin. Transfusion, 44: 838-843, 2004. (Pubitemid 38738411)
16. Hofheinz RD, Nguyen XD, Buchheidt D, Kerowgan M, Hehlmann R, Hochhaus: Two potential mechanisms of oxaliplatin- induced haemolytic anaemia in a single patient. Cancer Chemother Pharmacol, 53: 276-277, 2004. (Pubitemid 38293727)
17. Koutras AK, Makatsoris T, Paliogianni F, Kopsida G, Onyenadum A, Gogos CA: Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis. Oncology, 67: 179-182, 2004.
18. Taleghani BM, Fontana S, Meyer O, Ahrens N, Novak U, Borner MM: Oxaliplatin-induced immune pancytopenia. Transfusion, 45: 704-708, 2005. (Pubitemid 40656382)
19. Noronha V, Burtness B, Murren J, Duffy TP: Oxaliplatin induces a delayed immune-mediated hemolytic anemia: a case report and review of the literature. Clin Colorectal Cancer, 5:283-286, 2005.
20. Curtis BR, Kaliszewsk J, Marques MB, Saif MW, Nabelle L, Blank J: Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin. Am J Hematol, 81: 193-198, 2006.
21. Tsai HM: Advances in the pathogenesis, diagnosis and treatment of thrombotic thrombocitopenic purpura. J Am Soc Nephol, 14: 1072-1081, 2003.
22. George J: How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood, 96: 1223-1229, 2000.
23. Tostivit I, Mougenot B: Adult haemolytic uraemic syndrome: causes and prognostic factors in the last decade. Nephrol Dial Transplant, 17: 1288-1234, 2002.
24. Michael M, Elliot EJ, Ridley GF, Hodson EM, Craig JC: Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. A systematic review. The Cochrane Collaboration, 2009.